Relation of Elevated Levels of Plasma Myeloperoxidase to Impaired Myocardial Microcirculation After Reperfusion in Patients With Acute Myocardial Infarction

American Journal of Cardiology

Volumn 105, Issue 7, 2010, Pages 922-929

  Yunoki, Kei ^a   Naruko, Takahiko ^a   Komatsu, Ryushi ^a   Shirai, Nobuyuki ^b   Nakagawa, Masashi ^b   Sugioka, Kenichi ^b   Ikura, Yoshihiro ^b   Kusano, Kengo Fukushima ^c   Itoh, Akira ^a   Haze, Kazuo ^a   Yoshiyama, Minoru ^b   Becker, Anton E ^d   Ueda, Makiko ^b  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; MYELOPEROXIDASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY STENT; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME BLOOD LEVEL; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE BLOOD FLOW; HEART MUSCLE REPERFUSION; HEART VENTRICLE REMODELING; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROCIRCULATION; NEUTROPHIL; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS;

AGED; CORONARY CIRCULATION; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PEROXIDASE; STENTS; STROKE VOLUME;

EID: 77949570636     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.11.013     Document Type: Article

References (29)

1. Zhang R., Brennan M.L., Shen Z., MacPherson J.C., Schmitt D., Molenda C.E., and Hazen S.L. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem 277 (2002) 46116-46122
2. Podrez E.A., Schmitt D., Hoff H.F., and Hazen S.L. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro. J Clin Invest 103 (1999) 1547-1560
3. Vita J.A., Brennan M.L., Gokce N., Mann S.A., Goormastic M., Shishehbor M.H., Penn M.S., Keaney Jr. J.F., and Hazen S.L. Serum myeloperoxidase levels independently predict endothelial dysfunction in humans. Circulation 110 (2004) 1134-1139
4. Mocatta T.J., Pilbrow A.P., Cameron V.A., Senthilmohan R., Frampton C.M., Richards A.M., and Winterbourn C.C. Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol 49 (2007) 1993-2000
5. Tsutamoto T., Sakai H., Ishikawa C., Fujii M., Tanaka T., Yamamoto T., Takashima H., Ohnishi M., Wada A., and Horie M. Direct comparison of transcardiac difference between brain natriuretic peptide (BNP) and N-terminal pro-BNP in patients with chronic heart failure. Eur J Heart Fail 9 (2007) 667-673
6. Brennan M.L., Penn M.S., Van Lente F., Nambi V., Shishehbor M.H., Aviles R.J., Goormastic M., Pepoy M.L., McErlean E.S., Topol E.J., Nissen S.E., and Hazen S.L. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349 (2003) 1595-1604
7. Feldman L.J., Coste P., Furber A., Dupouy P., Slama M.S., Monassier J.P., Tron C., Lafont A., Faraggi M., Le Guludec D., Dubois-Randé J.L., Steg P.G., and FRench Optimal Stenting (FROST)-2 Investigators. Incomplete resolution of ST-segment elevation is a marker of transient microcirculatory dysfunction after stenting for acute myocardial infarction. Circulation 107 (2003) 2684-2689
8. van't Hof A.W., Liem A., Suryapranata H., Hoorntje J.C., de Boer M.J., and Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Circulation 97 (1998) 2302-2306
9. Santoro G.M., Valenti R., Buonamici P., Bolognese L., Cerisano G., Moschi G., Trapani M., Antoniucci D., and Fazzini P.F. Relation between ST-segment changes and myocardial perfusion evaluated by myocardial contrast echocardiography in patients with acute myocardial infarction treated with direct angioplasty. Am J Cardiol 82 (1998) 932-937
10. Tomai F., Ribichini F., Ghini A.S., Ferrero V., Ando G., Vassanelli C., Romeo F., Crea F., and Chiariello L. Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease. Eur Heart J 26 (2005) 2099-2105
11. Mazzone A., De Servi S., Ricevuti G., Mazzucchelli I., Fossati G., Pasotti D., Bramucci E., Angoli L., Marsico F., and Specchia G. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 88 (1993) 358-363
12. Mega J.L., Morrow D.A., de Lemos J.A., Sabatine M.S., Murphy S.A., Rifai N., Gibson C.M., Antman E.M., and Braunwald E. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI 23 substudy. J Am Coll Cardiol 44 (2004) 335-339
13. Lorgis L., Zeller M., Dentan G., Sicard P., Jolak M., L'Huillier I., Vincent-Martin M., Beer J.C., Makki H., Gambert P., and Cottin Y. High levels of N-terminal pro B-type natriuretic peptide are associated with ST resolution failure after reperfusion for acute myocardial infarction. Q J Med 100 (2007) 211-216
14. 2 radicals during reperfusion after prolonged myocardial ischemia. Am J Physiol Heart Circ Physiol 280 (2001) H2649-H2657
15. Golino P., Ragni M., Cirillo P., Avvedimento V.E., Feliciello A., Esposito N., Scognamiglio A., Trimarco B., Iaccarino G., Condorelli M., Chiariello M., and Ambrosio G. Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat Med 2 (1996) 35-40
16. Tritto I., Wang P., Kuppusamy P., Giraldez R., Zweier J.L., and Ambrosio G. The anti-anginal drug trimetazidine reduces neutrophil-mediated cardiac reperfusion injury. J Cardiovasc Pharmacol 46 (2005) 89-98
17. Ambrosio G., Weisman H.F., Mannisi J.A., and Becker L.C. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 80 (1989) 1846-1861
18. Biasucci L.M., D'Onofrio G., Liuzzo G., Zini G., Monaco C., Caligiuri G., Tommasi M., Rebuzzi A.G., and Maseri A. Intracellular neutrophil myeloperoxidase is reduced in unstable angina and acute myocardial infarction, but its reduction is not related to ischemia. J Am Coll Cardiol 27 (1996) 611-616
19. Buffon A., Biasucci L.M., Liuzzo G., D'Onofrio G., Crea F., and Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 347 (2002) 5-12
20. Naruko T., Ueda M., Haze K., van der Wal A.C., van der Loos C.M., Itoh A., Komatsu R., Ikura Y., Ogami M., Shimada Y., Ehara S., Yoshiyama M., Takeuchi K., Yoshikawa J., and Becker A.E. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 106 (2002) 2894-2900
21. Eiserich J.P., Baldus S., Brennan M.L., Ma W., Zhang C., Tousson A., Castro L., Lusis A.J., Nauseef W.M., White C.R., and Freeman B.A. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 296 (2002) 2391-2394
22. Zhang C., Reiter C., Eiserich J.P., Boersma B., Parks D.A., Beckman J.S., Barnes S., Kirk M., Baldus S., Darley-Usmar V.M., and White C.R. L-arginine chlorination products inhibit endothelial nitric oxide production. J Biol Chem 276 (2001) 27159-27165
23. Auchère F., and Capeillère-Blandin C. NADPH as a co-substrate for studies of the chlorinating activity of myeloperoxidase. Biochem J 343 (1999) 603-613
24. Sugiyama S., Kugiyama K., Aikawa M., Nakamura S., Ogawa H., and Libby P. Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis. Arterioscler Thromb Vasc Biol 24 (2004) 1309-1314
25. Baldus S., Heitzer T., Eiserich J.P., Lau D., Mollnau H., Ortak M., Petri S., Goldmann B., Duchstein H.J., Berger J., Helmchen U., Freeman B.A., Meinertz T., and Munzel T. Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion. Free Radic Biol Med 37 (2004) 902-911
26. Vasilyev N., Williams T., Brennan M.L., Unzek S., Zhou X., Heinecke J.W., Spitz D.R., Topol E.J., Hazen S.L., and Penn M.S. Myeloperoxidase-generated oxidants modulate left ventricular remodeling but not infarct size after myocardial infarction. Circulation 112 (2005) 2812-2820
27. Askari A.T., Brennan M.L., Zhou X., Drinko J., Morehead A., Thomas J.D., Topol E.J., Hazen S.L., and Penn M.S. Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction. J Exp Med 197 (2003) 615-624
28. de Lemos J.A., Antman E.M., Giugliano R.P., McCabe C.H., Murphy S.A., Van de Werf F., Gibson C.M., and Braunwald E. ST-segment resolution and infarct related artery patency and flow after thrombolytic therapy. Am J Cardiol 85 (2000) 299-304
29. Buszman P., Szafranek A., Kalarus Z., and Gasior M. Use of changes in ST segment elevation for prediction of infarct artery recanalization in acute myocardial infarction. Eur Heart J 16 (1995) 1207-1214